Hidenori Tanaka

发表

Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients.

K. Hirata, H. Kanazawa, K. Asai, 2011, Respiratory medicine.

Plasma concentration of amrubicinol in plateau phase in patients treated for 3 days with amrubicin is correlated with hematological toxicities

S. Kudoh, K. Hirata, Tatsuo Kimura, 2009, Anti-cancer drugs.

LBA54 Randomized phase III trial of nivolumab in combination with carboplatin, paclitaxel, and bevacizumab as first-line treatment for patients with advanced or recurrent non-squamous NSCLC

Teruhiko Yoshida, Y. Ohe, M. Nishio, 2020 .

Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations.

S. Kudoh, K. Hirata, K. Matsuura, 2013, Osaka city medical journal.

C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin

S. Kudoh, K. Hirata, K. Matsuura, 2013 .

Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR

A. Kubo, S. Kudoh, K. Hirata, 2016, Expert opinion on pharmacotherapy.

Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines

C. Sakakura, T. Chiba, Yoshiaki Ito, 2003, Oncogene.

Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort

J. Yokota, M. Oda, Y. Yatabe, 2011 .

Reaction of plasma hepatocyte growth factor levels in non‐small cell lung cancer patients treated with EGFR‐TKIs

M. Noguchi, S. Kudoh, K. Hirata, 2011, International journal of cancer.

Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer

S. Kudoh, K. Hirata, K. Matsuura, 2012, BMC Cancer.

Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non–small Cell Lung Cancer: The Final Report

S. Kudoh, K. Hirata, Tatsuo Kimura, 2017, American journal of clinical oncology.

Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy.

K. Hirata, Tatsuo Kimura, H. Kanazawa, 2019, Journal of thoracic disease.

OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)

M. Okada, T. Nakano, Y. Ohe, 2018, Journal of Thoracic Oncology.

Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort

T. Mitsudomi, K. Kiura, H. Uramoto, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.